Amarin Corporation, maker of EPA drug Vascepa, has sued two omega-3s finished good manufacturers for unfair trade practices for allegedly using the results of the company’s large scale drug trial to market their own fish-oil based dietary supplements.
The Nagoya Protocol, the big changes coming for Lactobacillus classification, and how to boost your chances of success with an NDI notification were just some of the topic covered during the third annual IPA Workshop in DC.
Many studies have linked polyphenols—chemical compounds found in everything from chocolate to olives to berries—to reduced cardiovascular disease risk. French researchers took a closer look at how different types of polyphenols relate to this risk.
A focus on inflammatory processes underlies much of innovation in the healthy aging space, according to panelists on a recent NutraIngredients-USA event. Another key takeaway: These concerns are starting earlier in life for today’s consumers.
A delivery system based on food-grade lecithin may boost the bioavailability of quercetin, a flavonoid linked to numerous health benefits but known to have poor low water solubility, low stability, and low bioavailability.
Gencor has announced it will introduce a new version of an older, under-the-radar dietary ingredient. The new offering, called Levagen, is a branded form of palmitoylethanolamide (PEA), an endocannabinoid-like molecule with potent anti inflammatory properties.
A randomised, cross-over study that investigated the impact of Actazin green and Livaux gold kiwifruit supplements on faecal microbial composition and metabolites in healthy and functionally constipated (FC) participants was the top-rated poster at our...
The source of CBD should be of concern for the companies marketing the ingredient, said a legal expert at a recent dietary supplement industry event. But he also said the regulatory landscape for the ingredient is shifting so fast that any opinions he...